{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:41:12Z","timestamp":1789389672473,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.10.053","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T18:31:01Z","timestamp":1196879461000},"page":"82-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia"],"prefix":"10.1016","volume":"26","author":[{"given":"Marjatta","family":"Sinisalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Vilpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"It\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja","family":"V\u00e4kev\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyrki","family":"Taurio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Aittoniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.10.053_bib1","first-page":"374","article-title":"Infections in chronic lymphocytic leukaemia. Analysis of incidence as a function of length of follow-up","volume":"78","author":"Molica","year":"1993","journal-title":"Haematologica"},{"key":"10.1016\/j.vaccine.2007.10.053_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0609.1992.tb01805.x","article-title":"Infections and serum IgG levels in patients with chronic lymphocytic leukaemia","volume":"48","author":"It\u00e4l\u00e4","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib3","first-page":"98","article-title":"The infectious complications of chronic lymphocytic leukemia","volume":"25","author":"Morrison","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/10428199409056283","article-title":"Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment","volume":"13","author":"Molica","year":"1994","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.vaccine.2007.10.053_bib5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4065\/75.10.1039","article-title":"Infection and immunity in CLL (review)","volume":"75","author":"Tsiodras","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2007.10.053_bib6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0272-2712(18)30704-2","article-title":"Immunobiology of malignant B-cells and immunoregulatory cells in B-chronic lymphocytic leukemia","volume":"8","author":"Kay","year":"1988","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.vaccine.2007.10.053_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0268-960X(90)90044-S","article-title":"Immunoregulatory cell dysfunction in chronic B-cell leukemias","volume":"4","author":"Zaknoen","year":"1990","journal-title":"Blood Rev"},{"key":"10.1016\/j.vaccine.2007.10.053_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-cell chronic lymphocytic leukemia: a bird of a different feather","volume":"17","author":"Caligaris-Cappio","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib9","first-page":"291","article-title":"Mechanism of infection in chronic lymphocytic leukemia","volume":"24","author":"Chapel","year":"1987","journal-title":"Semin Hematol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0609.1996.tb00489.x","article-title":"Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia","volume":"57","author":"It\u00e4l\u00e4","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib11","first-page":"1509","article-title":"The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives","volume":"10","author":"Schlesinger","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2007.10.053_bib12","first-page":"4497","article-title":"The circulating dendritic cell compartment in patients with chronic lymphocytic leukaemia is severely defective and unable to stimulate an effective T-cell response","volume":"63","author":"Orsini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2007.10.053_bib13","doi-asserted-by":"crossref","unstructured":"Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in CLL. N Eng J Med 1988;319:902\u20137.","DOI":"10.1056\/NEJM198810063191403"},{"key":"10.1016\/j.vaccine.2007.10.053_bib14","first-page":"121","article-title":"Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukaemia. Results of a crossover study","volume":"81","author":"Molica","year":"1996","journal-title":"Haematologica"},{"key":"10.1016\/j.vaccine.2007.10.053_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/1042819031000063408","article-title":"Vaccination against infections in chronic lymphocytic leukaemia (review)","volume":"44","author":"Sinisalo","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.vaccine.2007.10.053_bib16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0264-410X(00)00409-6","article-title":"Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia","volume":"19","author":"Hartkamp","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.053_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2141.2001.02882.x","article-title":"Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia","volume":"114","author":"Sinisalo","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","article-title":"Conjugate vaccines","volume":"119","author":"Goldblatt","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib19","series-title":"WHO Classification of Tumours, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"127","article-title":"Chronic lymphocytic leukaemia\/small lymphocytic lymphoma","author":"M\u00fcller-Hermelink","year":"2001"},{"key":"10.1016\/j.vaccine.2007.10.053_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/infdis\/172.5.1273","article-title":"Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children","volume":"172","author":"K\u00e4yhty","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2007.10.053_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/CDLI.8.2.266-272.2001","article-title":"Pneumococcal type 22F polysaccharide adsorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay","volume":"8","author":"Concepcion","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/cdli.2.5.590-597.1995","article-title":"Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S","volume":"5","author":"Quataert","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib23","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"J\u00f3dar","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.053_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"on the behalf of The International Familial CLL Consortium. Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2007.10.053_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI102741","article-title":"Quantitative antibody studies in man, III: Antibody response in leukemia and other malignant lymphomata","volume":"32","author":"Larson","year":"1953","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.10.053_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archinte.1960.03820040005002","article-title":"Infection and autoimmunity in chronic lymphocytic leukaemia","volume":"106","author":"Shaw","year":"1960","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2007.10.053_bib27","first-page":"1902","article-title":"Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukaemia","volume":"9","author":"Jurlander","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2007.10.053_bib28","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1080\/1042819021000015916","article-title":"Haemophilus influenzae type b (Hib) antibody concentrations and vaccination responses in patients with chronic lymphocytic leukaemia: predicting factors for response","volume":"43","author":"Sinisalo","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.vaccine.2007.10.053_bib29","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995\u20131998: Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.10.053_bib30","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1016\/j.vaccine.2007.02.062","article-title":"Immunogenicity of varying dosages of 7-valent pneumococcal-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"25","author":"Jackson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.10.053_bib31","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0264-410X(00)00232-2","article-title":"Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults","volume":"19","author":"Kroon","year":"2001","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07012200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:22Z","timestamp":1759400122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07012200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07012200"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}